Tapentadol Extended-Release Tablets and Trastuzumab and Hyaluronidase
Determining the interaction of Tapentadol Extended-Release Tablets and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: tapentadol
Brand name: Nucynta, Nucynta ER
Synonyms: Tapentadol
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Tapentadol Extended-Release Tablets-Trastuzumab Injection (Intravenous)
- Tapentadol Extended-Release Tablets-Trastuzumab Intravenous
- Tapentadol Extended-Release Tablets-Trastuzumab-anns
- Tapentadol Extended-Release Tablets-Trastuzumab-dkst
- Tapentadol Extended-Release Tablets-Trastuzumab-dkst Intravenous
- Tapentadol Extended-Release Tablets-Trasylol
- Trastuzumab and Hyaluronidase-Tapentadol Hydrochloride
- Trastuzumab and Hyaluronidase-Tapentadol Tablets
- Trastuzumab and Hyaluronidase-TaperDex 12-day
- Trastuzumab and Hyaluronidase-TaperDex 6-day
- Trastuzumab and Hyaluronidase-TaperDex 7-day
- Trastuzumab and Hyaluronidase-Tar Distillate Topical